Skip to main content

Week in Review: December 7–11

Effects of experimental brain manipulations questioned; long-lived memory T cells; more GM microbe “kill switches”; CRISPR therapy in a dish

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

WIKIMEDIA, PERIPITUSIn rats and zebra finches, transient brain manipulations show different functional effects than permanent lesions in the same regions, a team led by investigators at Harvard reported this week (December 9) in Nature. Further, the researchers showed that both transient inactivation and stimulation of a particular region in the rat brain impaired the animal’s performance on a given task, hinting at acute widespread circuit dysfunction that could confuse research results.

“This is a paper that had to be done,” said Giulio Tononi of the University of Wisconsin who was not involved in the study. “The work is very elegant, very careful, and it shows something that one could definitely suspect . . . but that has never been shown so explicitly.”

FLICKR, NIAIDSynthetic gene circuits called “kill switches” ensure that genetically modified (GM) bacteria survive only under certain environmental conditions. This week (December 7) in Nature Chemical Biology, an MIT-led team described two such circuits, which could be used to rein in engineered microbes designed for environmental remediation efforts, among other things.

“This is yet another step forward towards better biosafety and biocontainment based on certain aspects of existing technology,” said Guy-Bart Stan of Imperial College London who was not involved in the study. “Using some existing genetic circuitry . . . you can obtain biosafety for the here and now.”

WIKIMEDIA, NCIScientists in Milan have identified two types of memory T cells that stand the test of time. The team sampled the blood of patients who had received hematopoietic stem cell transplants spiked with genetically marked donor memory T cells and showed that two types of memory T cells can persist in people for up to 14 years. The results were published this week (December 9) in Science Translational Medicine.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo